QUAGLINO, Pietro

QUAGLINO, Pietro  

SCIENZE MEDICHE  

Mostra records
Risultati 1 - 20 di 608 (tempo di esecuzione: 0.022 secondi).
Titolo Data di pubblicazione Autore(i) File
'Aleukemic' granulomatous leukemia cutis. 1998 TOMASINI C ;QUAGLINO P ;NOVELLI M ;FIERRO MT
1975-2011 Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed? 2012 Simone Ribero; Pietro Quaglino; Martina Sanlorenzo; Simona Osella-Abate; Federica Marenco; Tiziana Nardò; Giuseppe Macripò; Maria Teresa Fierro; Maria Grazia Bernengo
262 Brentuximab vedotin demonstrates superior activity to standard therapy in CD30-expressing (CD30+) cutaneous T-cell lymphoma (CTCL) in the randomized phase 3 ALCANZA study 2017 Kim, Y.H.; Whittaker, S.; Horwitz, S.M.; Duvic, M.; Dummer, R.; Scarisbrick, J.; Quaglino, P.; Zinzani, P.; Wolter, P.; Wang, Y.; Palanca-Wessels, M.; Zagadailov, E.; Trepicchio, W.L.; Lin, H.; Little, M.; Prince, H.
A Case of a Pigmented Epithelioid Melanocytoma on a Mucosal Site 2020 Ramondetta, Alice; Ribero, Simone; Conti, Luca; Quaglino, Pietro; Broganelli, Paolo
A literature revision in primary cutaneous B-cell lymphoma 2017 La Selva, R; Alberti Violetti, S.; Delfino, C.; Grandi, V.; Cicchelli, S.; Tomasini CF; Fierro, M.T.; Berti, E.; Pimpinelli, N.; Quaglino, P.
A meta-analysis of melanoma risk in industrial workers 2018 Vujic, Igor; Gandini, Sara; Stanganelli, Ignazio; Fierro, Maria T; Rappersberger, Klemens; Sibilia, Maria; Tosti, Giulio; Ferrucci, Pier F; Caini, Saverio; De Felici, Maria B; Pagliarello, Calogero; Quaglino, Pietro; Sanlorenzo, Martina
A multicenter, d ouble blind, randomized, placebo-controlled, phase II trial to evaluate resminostat for maintenance treatment of patients with advanced stage (stage IIB–IVB) mycosis fungoides (MF) or Sézary syndrome (SS) that have achieved disease control with systemic therapy: the RESMAIN study 2019 Stadler, R.; Scarisbrick, J.; Knobler, R.; Quaglino, P.; Borgmann, M.; Orlovius, M.; Reimann, P.; Danhauser-Riedl, S.
A new T helper subset producing Interleukin 22 increases in multiplesclerosis patients. 2011 Simona Rolla; Valentina Bardina; Marinella Clerico; Paola Bonaventura; Pietro Quaglino; Giulia Contessa; Luca Durelli; Francesco Novelli
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs. 2017 Bagot M, Hasan B, Whittaker S, Beylot-Barry M, Knobler R, Shah E., Marreaud S, Morris S, Dalle S, Servitje O, Cowan R, Väkevä L, Chaby G, Jonak C., Fox C.P., Ritchie D, Vermeer M.H., Stadler R., Romero P.L.O., Scarisbrick J., Quaglino, P.
A project by the SIDeMaST Immunopathology Group on cutaneous vasculitis 2015 Papini, M; Quaglino, P.; La Placa, M.; Marzano, A.V.
A retrospective analysis of dabrafenib and/or dabrafenib plus trametinib combination in patients with metastatic melanoma to characterize patients with long-term benefit in the individual patient program (Describe iii) 2021 Atkinson V.G.; Quaglino P.; Aglietta M.; Del Vecchio M.; Depenni R.; Consoli F.; Bafaloukos D.; Ferrucci P.F.; Tulyte S.; Krajsova I.; Ascierto P.A.; Gueli R.; Arance A.; Gogas H.; Banerjee H.; Saliba T.; de Jong E.; Neyns B.
A simple scoring system for the diagnosis of palmo-plantar pigmented skin lesions by digital dermoscopy analysis. 2012 Rubegni P; Cevenini G; Nami N; Argenziano G; Saida T; Burroni M; Quaglino P; Bono R; Hofmann-Wellenhof R; Fimiani M.
A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert-Bazin type) mycosis fungoides. 2014 Ferrara G; Pancione M; Votino C; Quaglino P; Tomasini C; Santucci M; Pimpinelli N; Cusano F; Sabatino L; Colantuoni V.
A traveller's wart: tungiasis 2018 Fava, Paolo; Astrua, Chiara; Brizio, Matteo; Cavaliere, Giovanni; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro
Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies 2017 Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Donini, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario
Activity and safety of bexarotene as maienance therapy in CTCL patients with stable disease or remission after systemic treatments: a prospective multicenter trial from the GILC 2011 Quaglino P
Activity and safety of bexarotene as maintainance therapy in advanced/aggressive CTCL patients with stable disease or remission after systemic treatment: an observational multicenter trial from the GILC 2007 Pietro Quaglino; Maria Grazia Bernengo
Activity and safety of Bexarotene as maintenance therapy in CTCL patients (Mycosis Fungoides stage IIB-IV, Sezary Syndrome, peripheral T-cell lymphoma) with stable disease or remission after systemic treatments: A prospective multicenter trauil from the Italian Group of Cutaneous Lymphoma (GILC) 2011 Quaglino P;Pimpinelli N; Alaibac M; Quintini G; Bernengo MG
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era 2021 Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone
Acute digital gangrene in a long-term dialysis patient -- a diagnostic challenge. 2002 PICCOLI GB; QUAGLIA M; QUAGLINO P; BURDESE M; BERMOND F; MEZZA E; JEANTET A; SEGOLONI GP